New biotech launched for antisense program targeting Angelman syndrome
February 22, 2018 09:11 ET
|
GeneTx Biotherapeutics
Downers Grove, Ill., Feb. 22, 2018 (GLOBE NEWSWIRE) -- FAST (Foundation for Angelman Syndrome Therapeutics) announced today the launch of GeneTx Biotherapeutics LLC (GeneTx), a subsidiary of FAST,...